Literature DB >> 12095873

Experimental cutaneous Leishmaniasis: a powerful model to study in vivo the mechanisms underlying genetic differences in Th subset differentiation.

Jacques Louis1, Alain Gumy, Heike Voigt, Martin Röcken, Pascal Launois.   

Abstract

The murine model of infection with Leishmania major has allowed the demonstration in vivo of the importance CD4+ T cell subsets, distinguishable by the pattern of cytokines they produce, on the outcome of infectious diseases. Genetically determined resistance and susceptibility to infection with this parasite are the result of the development of Th1 and Th2 response, respectively. In this short paper, we present some results obtained in our group pertaining to the analysis of the mechanisms, operational during the early phase of this infection, responsible for the maturation of these functionally distinct CD4+ responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095873

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  6 in total

1.  High levels of susceptibility and T helper 2 response in MyD88-deficient mice infected with Leishmania major are interleukin-4 dependent.

Authors:  Andrea Debus; Joachim Gläsner; Martin Röllinghoff; André Gessner
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

2.  Real-time in vivo green fluorescent protein imaging of a murine leishmaniasis model as a new tool for Leishmania vaccine and drug discovery.

Authors:  Sanjay R Mehta; Robert Huang; Meng Yang; Xing-Quan Zhang; Bala Kolli; Kwang-Poo Chang; Robert M Hoffman; Yasuyuki Goto; Roberto Badaro; Robert T Schooley
Journal:  Clin Vaccine Immunol       Date:  2008-10-22

Review 3.  Visceral leishmaniasis: experimental models for drug discovery.

Authors:  Suman Gupta
Journal:  Indian J Med Res       Date:  2011-01       Impact factor: 2.375

4.  Genomic organization of leishmania species.

Authors:  B Kazemi
Journal:  Iran J Parasitol       Date:  2011-08       Impact factor: 1.012

Review 5.  A new view on cutaneous dendritic cell subsets in experimental leishmaniasis.

Authors:  Uwe Ritter; Anke Osterloh
Journal:  Med Microbiol Immunol       Date:  2006-06-20       Impact factor: 4.148

Review 6.  A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis.

Authors:  Emily Rose Mears; Farrokh Modabber; Robert Don; George E Johnson
Journal:  PLoS Negl Trop Dis       Date:  2015-09-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.